{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:43:29Z","timestamp":1780393409913,"version":"3.54.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Despite increasing in vitro research, direct evidence of how abnormal \u03b1-synuclein (\u03b1-Syn) dysregulates vesicular transport and synaptic function in the human brain is lacking.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We performed a transcriptome analysis using brain tissues from a multiple system atrophy (MSA) mouse model, which develops human \u03b1-Syn-positive glial cytoplasmic inclusion-like structures and neuronal cytoplasmic inclusion-like structures after tamoxifen injection. We then performed histologic and biochemical analyses using brain samples from 71 human cases (Parkinson\u2019s disease, <jats:italic>n<\/jats:italic>\u2009=\u200910; dementia with Lewy bodies [DLB], <jats:italic>n<\/jats:italic>\u2009=\u200919; MSA, <jats:italic>n<\/jats:italic>\u2009=\u200915; control: <jats:italic>n<\/jats:italic>\u2009=\u200927), a human blood sample (control: <jats:italic>n<\/jats:italic>\u2009=\u20091), and cultured cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Based on the transcriptome of the MSA mouse model, we identified 10 vesicular transport proteins, including synaptotagmin 13 (SYT13), that might interact with \u03b1-Syn. Immunohistochemistry using human brain samples demonstrated that of the 10 vesicular transport proteins identified in the transcriptome analysis, only SYT13 was incorporated into both Lewy bodies and glial cytoplasmic inclusions. Proximity ligation assays revealed that SYT13 exhibited a higher degree of interactions with phosphorylated \u03b1-Syn than with endogenous \u03b1-Syn. Immunoprecipitation confirmed that SYT13 bound predominantly to phosphorylated \u03b1-Syn, SYT1, and the soluble N-ethylmaleimide-sensitive attachment protein receptor (SNARE) complexes. Filter trap assays revealed interactions between SYT13 and soluble toxic \u03b2-sheet-rich \u03b1-Syn oligomers. Furthermore, fraction analysis showed a significant increase of SYT13 protein levels at the synapses in DLB and MSA. Notably, a correlation was observed between the levels of SYT13 and aggregated \u03b1-Syn at the synapses. SYT13 was observed to regulate extracellular vesicle release in association with SYT1 and the SNARE complexes in SH-SY5Y cells. SYT13 overexpression in SH-SY5Y cells impaired extracellular vesicle release. Consistently, the numbers of extracellular vesicles were significantly reduced in the brain homogenates of DLB and MSA cases compared with those in controls.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Abnormal \u03b1-Syn impairs extracellular vesicle release through interactions with SYT13 in synucleinopathies. Our findings provide insights into therapeutic strategies for alleviating dysregulations of vesicular transport and synaptic function in patients with synucleinopathies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40035-025-00493-6","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T04:50:11Z","timestamp":1750654211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Abnormal \u03b1-synuclein binds to synaptotagmin 13, impairing extracellular vesicle release in synucleinopathies"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9375-9590","authenticated-orcid":false,"given":"Yasuo","family":"Miki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Shimoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto T.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanae","family":"Kushibiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asa","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Hijioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Kon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megha","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concei\u00e7\u00e3o","family":"Bettencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirushi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Kakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas T.","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"493_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","volume":"251","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson\u2019s disease and dementia with Lewy bodies. Neurosci Lett. 1998;251:205\u20138.","journal-title":"Neurosci Lett"},{"key":"493_CR2","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A. 1998;95:6469\u201373.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"493_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","volume":"249","author":"K Wakabayashi","year":"1998","unstructured":"Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H. Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett. 1998;249:180\u20132.","journal-title":"Neurosci Lett"},{"key":"493_CR4","doi-asserted-by":"publisher","first-page":"106535","DOI":"10.1016\/j.nbd.2024.106535","volume":"197","author":"S Lee","year":"2024","unstructured":"Lee S, Martinez-Valbuena I, Lang AE, Kovacs GG. Cellular iron deposition patterns predict clinical subtypes of multiple system atrophy. Neurobiol Dis. 2024;197:106535.","journal-title":"Neurobiol Dis"},{"key":"493_CR5","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1111\/febs.14607","volume":"285","author":"DJ Surmeier","year":"2018","unstructured":"Surmeier DJ. Determinants of dopaminergic neuron loss in Parkinson\u2019s disease. FEBS J. 2018;285:3657\u201368.","journal-title":"FEBS J"},{"key":"493_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1212\/WNL.0000000000001807","volume":"85","author":"S Koga","year":"2015","unstructured":"Koga S, Aoki N, Uitti RJ, van Gerpen JA, Cheshire WP, Josephs KA, et al. When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients. Neurology. 2015;85:404\u201312.","journal-title":"Neurology"},{"key":"493_CR7","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1093\/brain\/awaa126","volume":"143","author":"Y Miki","year":"2020","unstructured":"Miki Y, Foti SC, Hansen D, Strand KM, Asi YT, Tsushima E, et al. Hippocampal \u03b1-synuclein pathology correlates with memory impairment in multiple system atrophy. Brain. 2020;143:1798\u2013810.","journal-title":"Brain"},{"key":"493_CR8","doi-asserted-by":"publisher","first-page":"e12844","DOI":"10.1111\/nan.12844","volume":"48","author":"Y Miki","year":"2022","unstructured":"Miki Y, Tanji K, Shinnai K, Tanaka MT, Altay F, Foti SC, et al. Pathological substrate of memory impairment in multiple system atrophy. Neuropathol Appl Neurobiol. 2022;48:e12844.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"493_CR9","doi-asserted-by":"publisher","first-page":"fcae193","DOI":"10.1093\/braincomms\/fcae193","volume":"6","author":"TM Tanaka","year":"2024","unstructured":"Tanaka TM, Miki Y, Mori F, Kon T, Furukawa T, Shimoyama S, et al. Intranasal administration of trehalose reduces \u03b1-synuclein oligomers and accelerates \u03b1-synuclein aggregation. Brain Commun. 2024;6:fcae193.","journal-title":"Brain Commun."},{"key":"493_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89:88\u2013100.","journal-title":"Neurology"},{"key":"493_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12035-012-8280-y","volume":"47","author":"K Wakabayashi","year":"2013","unstructured":"Wakabayashi K, Tanji K, Odagiri S, Miki Y, Mori F, Takahashi H. The Lewy body in Parkinson\u2019s disease and related neurodegenerative disorders. Mol Neurobiol. 2013;47:495\u2013508.","journal-title":"Mol Neurobiol"},{"key":"493_CR12","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1212\/WNL.53.9.2003","volume":"53","author":"T G\u00f3mez-Isla","year":"1999","unstructured":"G\u00f3mez-Isla T, Growdon WB, McNamara M, Newell K, G\u00f3mez-Tortosa E, Hedley-Whyte ET, et al. Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies. Neurology. 1999;53:2003\u20139.","journal-title":"Neurology"},{"key":"493_CR13","doi-asserted-by":"publisher","first-page":"fcab049","DOI":"10.1093\/braincomms\/fcab049","volume":"3","author":"JC Bridi","year":"2021","unstructured":"Bridi JC, Bereczki E, Smith SK, Po\u00e7as GM, Kottler B, Domingos PM, et al. Presynaptic accumulation of \u03b1-synuclein causes synaptopathy and progressive neurodegeneration. Brain Commun. 2021;3:fcab049.","journal-title":"Brain Commun."},{"key":"493_CR14","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1093\/brain\/awad150","volume":"146","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Di Lazzaro G, Marino G, Campanelli F, Ghiglieri V. Advances in understanding the function of alpha-synuclein: implication for Parkinson\u2019s disease. Brain. 2023;146:3587\u201397.","journal-title":"Brain"},{"key":"493_CR15","doi-asserted-by":"publisher","first-page":"14178","DOI":"10.1073\/pnas.1914670117","volume":"117","author":"JK Hannestad","year":"2020","unstructured":"Hannestad JK, Rocha S, Agnarsson B, Zhdanov VP, Wittung-Stafshede P, H\u00f6\u00f6k F. Single-vesicle imaging reveals lipid-selective and stepwise membrane disruption by monomeric \u03b1-synuclein. Proc Natl Acad Sci U S A. 2020;117:14178\u201386.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"493_CR16","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burr\u00e9","year":"2010","unstructured":"Burr\u00e9 J, Sharma M, Tsetsenis T, Buchman V, Etherton MR, S\u00fcdhof TC. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science. 2010;329:1663\u20137.","journal-title":"Science"},{"key":"493_CR17","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nn.4529","volume":"20","author":"T Logan","year":"2017","unstructured":"Logan T, Bendor J, Toupin C, Thorn K, Edwards RH. \u03b1-Synuclein promotes dilation of the exocytotic fusion pore. Nat Neurosci. 2017;20:681\u20139.","journal-title":"Nat Neurosci"},{"key":"493_CR18","doi-asserted-by":"publisher","first-page":"11113","DOI":"10.1073\/pnas.1903049116","volume":"116","author":"J Sun","year":"2019","unstructured":"Sun J, Wang L, Bao H, Premi S, Das U, Chapman ER, et al. Functional cooperation of alpha-synuclein and VAMP2 in synaptic vesicle recycling. Proc Natl Acad Sci U S A. 2019;116:11113\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"493_CR19","doi-asserted-by":"publisher","first-page":"13709","DOI":"10.1021\/bi961799n","volume":"35","author":"PH Weinreb","year":"1996","unstructured":"Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT Jr. NACP, a protein implicated in Alzheimer\u2019s disease and learning, is natively unfolded. Biochemistry. 1996;35:13709\u201315.","journal-title":"Biochemistry"},{"key":"493_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4269","volume":"23","author":"YC Wong","year":"2017","unstructured":"Wong YC, Krainc D. \u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies. Nat Med. 2017;23:1\u201313.","journal-title":"Nat Med"},{"key":"493_CR21","doi-asserted-by":"publisher","first-page":"e13001","DOI":"10.1111\/bpa.13001","volume":"31","author":"F Mori","year":"2021","unstructured":"Mori F, Miki Y, Tanji K, Kon T, Tomiyama M, Kakita A, et al. Role of VAPB and vesicular profiles in \u03b1-synuclein aggregates in multiple system atrophy. Brain Pathol. 2021;31:e13001.","journal-title":"Brain Pathol"},{"key":"493_CR22","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/jnen\/nlac070","volume":"81","author":"F Mori","year":"2022","unstructured":"Mori F, Nakamura Y, Miki Y, Tanji K, Kon T, Tomiyama M, et al. Alteration of vesicle-associated membrane protein-binding protein B in \u03b1-synuclein aggregates in Lewy body disease. J Neuropathol Exp Neurol. 2022;81:920\u201330.","journal-title":"J Neuropathol Exp Neurol"},{"key":"493_CR23","doi-asserted-by":"publisher","first-page":"20051","DOI":"10.1073\/pnas.0908005106","volume":"106","author":"KC Luk","year":"2009","unstructured":"Luk KC, Song C, O\u2019Brien P, Stieber A, Branch JR, Brunden KR, et al. Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci U S A. 2009;106:20051\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"493_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley LA, Luk KC, Patel TP, Tanik SA, Riddle DM, Stieber A, et al. Exogenous \u03b1-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron. 2011;72:57\u201371.","journal-title":"Neuron"},{"key":"493_CR25","doi-asserted-by":"publisher","first-page":"e78055","DOI":"10.7554\/eLife.78055","volume":"11","author":"L Chen","year":"2022","unstructured":"Chen L, Nagaraja C, Daniels S, Fisk ZA, Dvorak R, Meyerdirk L, et al. Synaptic location is a determinant of the detrimental effects of \u03b1-synuclein pathology to glutamatergic transmission in the basolateral amygdala. Elife. 2022;11:e78055.","journal-title":"Elife"},{"key":"493_CR26","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1073\/pnas.1218424110","volume":"110","author":"BK Choi","year":"2013","unstructured":"Choi BK, Choi MG, Kim JY, Yang Y, Lai Y, Kweon DH, et al. Large \u03b1-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking. Proc Natl Acad Sci U S A. 2013;110:4087\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"493_CR27","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/embor.2010.66","volume":"11","author":"F Darios","year":"2010","unstructured":"Darios F, Ruip\u00e9rez V, L\u00f3pez I, Villanueva J, Gutierrez LM, Davletov B. Alpha-synuclein sequesters arachidonic acid to modulate SNARE-mediated exocytosis. EMBO Rep. 2010;11:528\u201333.","journal-title":"EMBO Rep"},{"key":"493_CR28","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1021\/bi4002369","volume":"52","author":"DC DeWitt","year":"2013","unstructured":"DeWitt DC, Rhoades E. \u03b1-Synuclein can inhibit SNARE-mediated vesicle fusion through direct interactions with lipid bilayers. Biochemistry. 2013;52:2385\u20137.","journal-title":"Biochemistry"},{"key":"493_CR29","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.nbd.2019.03.020","volume":"127","author":"K Tanji","year":"2019","unstructured":"Tanji K, Miki Y, Mori F, Nikaido Y, Narita H, Kakita A, et al. A mouse model of adult-onset multiple system atrophy. Neurobiol Dis. 2019;127:339\u201349.","journal-title":"Neurobiol Dis"},{"key":"493_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jphs.2024.07.008","volume":"156","author":"S Nozaki","year":"2024","unstructured":"Nozaki S, Hijioka M, Wen X, Iwashita N, Namba J, Nomura Y, et al. Galantamine suppresses \u03b1-synuclein aggregation by inducing autophagy via the activation of \u03b17 nicotinic acetylcholine receptors. J Pharmacol Sci. 2024;156:102\u201314.","journal-title":"J Pharmacol Sci"},{"key":"493_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/bpa.12461","volume":"28","author":"Y Miki","year":"2018","unstructured":"Miki Y, Tanji K, Mori F, Tatara Y, Utsumi J, Sasaki H, et al. (2018) AMBRA1, a novel \u03b1-synuclein-binding protein, is implicated in the pathogenesis of multiple system atrophy. Brain Pathol. 2018;28:28\u201342.","journal-title":"Brain Pathol"},{"key":"493_CR32","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, Goberdhan DCI, O\u2019Driscoll L, Buzas EI, Blenkiron C, Bussolati B, et al. Minimal information for studies of extracellular vesicle (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13:e12404.","journal-title":"J Extracell Vesicles"},{"key":"493_CR33","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/ncb2502","volume":"14","author":"MF Baietti","year":"2012","unstructured":"Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol. 2012;14:677\u201385.","journal-title":"Nat Cell Biol"},{"key":"493_CR34","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1093\/emboj\/20.4.683","volume":"20","author":"G Cantalupo","year":"2001","unstructured":"Cantalupo G, Alifano P, Roberti V, Bruni CB, Bucci C. Rab-interacting lysosomal protein (RILP): the Rab7 effector required for transport to lysosomes. EMBO J. 2001;20:683\u201393.","journal-title":"EMBO J"},{"key":"493_CR35","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1038\/s41467-018-05699-z","volume":"9","author":"J Emperador-Melero","year":"2018","unstructured":"Emperador-Melero J, Huson V, van Weering J, Bollmann C, Fischer von Mollard G, Toonen RF, et al. Vti1a\/b regulate synaptic vesicle and dense core vesicle secretion via protein sorting at the Golgi. Nat Commun. 2018;9:3421.","journal-title":"Nat Commun"},{"key":"493_CR36","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1046\/j.1600-0854.2003.00141.x","volume":"4","author":"TM Evans","year":"2003","unstructured":"Evans TM, Ferguson C, Wainwright BJ, Parton RG, Wicking C. Rab23, a negative regulator of hedgehog signaling, localizes to the plasma membrane and the endocytic pathway. Traffic. 2003;4:869\u201384.","journal-title":"Traffic"},{"key":"493_CR37","doi-asserted-by":"publisher","first-page":"103795","DOI":"10.1016\/j.mcn.2022.103795","volume":"124","author":"CC Garner","year":"2023","unstructured":"Garner CC, Ackermann F. Synaptic logistics: The presynaptic scaffold protein Piccolo a nodal point tuning synaptic vesicle recycling, maintenance and integrity. Mol Cell Neurosci. 2023;124:103795.","journal-title":"Mol Cell Neurosci"},{"key":"493_CR38","doi-asserted-by":"publisher","first-page":"14417","DOI":"10.1523\/JNEUROSCI.1236-13.2013","volume":"33","author":"R Mohrmann","year":"2013","unstructured":"Mohrmann R, de Wit H, Connell E, Pinheiro PS, Leese C, Bruns D, et al. Synaptotagmin interaction with SNAP-25 governs vesicle docking, priming, and fusion triggering. J Neurosci. 2013;33:14417\u201330.","journal-title":"J Neurosci"},{"key":"493_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ncb2000","volume":"12","author":"M Ostrowski","year":"2010","unstructured":"Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12:19\u201330.","journal-title":"Nat Cell Biol"},{"key":"493_CR40","doi-asserted-by":"publisher","first-page":"6187","DOI":"10.1073\/pnas.95.11.6187","volume":"95","author":"M Ren","year":"1998","unstructured":"Ren M, Xu G, Zeng J, De Lemos-Chiarandini C, Adesnik M, Sabatini DD. Hydrolysis of GTP on rab11 is required for the direct delivery of transferrin from the pericentriolar recycling compartment to the cell surface but not from sorting endosomes. Proc Natl Acad Sci U S A. 1998;95:6187\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"493_CR41","doi-asserted-by":"publisher","first-page":"e201304004","DOI":"10.5936\/csbj.201304004","volume":"7","author":"S Chandrasekaran","year":"2013","unstructured":"Chandrasekaran S, Bonchev D. A network view on Parkinson\u2019s disease. Comput Struct Biotechnol J. 2013;7:e201304004.","journal-title":"Comput Struct Biotechnol J"},{"key":"493_CR42","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1523\/JNEUROSCI.2229-12.2013","volume":"33","author":"E Alvarez-Baron","year":"2013","unstructured":"Alvarez-Baron E, Michel K, Mittelstaedt T, Opitz T, Schmitz F, Beck H, et al. RIM3\u03b3 and RIM4\u03b3 are key regulators of neuronal arborization. J Neurosci. 2013;33:824\u201339.","journal-title":"J Neurosci"},{"key":"493_CR43","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1126\/science.1161748","volume":"323","author":"TC Sudhof","year":"2009","unstructured":"Sudhof TC, Rothman JE. Membrane fusion: grappling with SNARE and SM proteins. Science. 2009;323:474\u20137.","journal-title":"Science"},{"key":"493_CR44","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1083\/jcb.135.4.913","volume":"135","author":"O Ullrich","year":"1996","unstructured":"Ullrich O, Reinsch S, Urb\u00e9 S, Zerial M, Parton RG. Rab11 regulates recycling through the pericentriolar recycling endosome. J Cell Biol. 1996;135:913\u201324.","journal-title":"J Cell Biol"},{"key":"493_CR45","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1083\/jcb.151.6.1207","volume":"151","author":"M Wilcke","year":"2000","unstructured":"Wilcke M, Johannes L, Galli T, Mayau V, Goud B, Salamero J. Rab11 regulates the compartmentalization of early endosomes required for efficient transport from early endosomes to the trans-golgi network. J Cell Biol. 2000;151:1207\u201320.","journal-title":"J Cell Biol"},{"key":"493_CR46","doi-asserted-by":"publisher","first-page":"BSR20160410","DOI":"10.1042\/BSR20160410","volume":"37","author":"LQ Zheng","year":"2017","unstructured":"Zheng LQ, Chi SM, Li CX. Rab23\u2019s genetic structure, function and related diseases: a review. Biosci Rep. 2017;37:BSR20160410.","journal-title":"Biosci Rep"},{"key":"493_CR47","doi-asserted-by":"publisher","first-page":"105086","DOI":"10.1016\/j.nbd.2020.105086","volume":"146","author":"ST Kumar","year":"2020","unstructured":"Kumar ST, Jagannath S, Francois C, Vanderstichele H, Stoops E, Lashuel HA. How specific are the conformation-specific \u03b1-synuclein antibodies? Characterization and validation of 16 \u03b1-synuclein conformation-specific antibodies using well-characterized preparations of \u03b1-synuclein monomers, fibrils and oligomers with distinct structures and morphology. Neurobiol Dis. 2020;146:105086.","journal-title":"Neurobiol Dis"},{"key":"493_CR48","doi-asserted-by":"publisher","first-page":"108842","DOI":"10.1016\/j.celrep.2021.108842","volume":"34","author":"Y Chen","year":"2021","unstructured":"Chen Y, Wang YH, Zheng Y, Li M, Wang B, Wang QW, et al. Synaptotagmin-1 interacts with PI(4,5)P2 to initiate synaptic vesicle docking in hippocampal neurons. Cell Rep. 2021;34:108842.","journal-title":"Cell Rep"},{"key":"493_CR49","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1078\/0171-9335-00133","volume":"80","author":"C von Poser","year":"2001","unstructured":"von Poser C, S\u00fcdhof TC. Synaptotagmin 13: structure and expression of a novel synaptotagmin. Eur J Cell Biol. 2001;80:41\u20137.","journal-title":"Eur J Cell Biol"},{"issue":"9","key":"493_CR50","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41531-023-00583-0","volume":"28","author":"N Ito","year":"2023","unstructured":"Ito N, Tsuji M, Adachi N, Nakamura S, Sarkar AK, Ikenaka K, et al. Extracellular high molecular weight \u03b1-synuclein oligomers induce cell death by disrupting the plasma membrane. NPJ Parkinsons Dis. 2023;28(9):139.","journal-title":"NPJ Parkinsons Dis"},{"key":"493_CR51","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/B978-0-323-85538-9.00008-0","volume":"192","author":"AJ Espay","year":"2023","unstructured":"Espay AJ, Herrup K, Daly T. Finding the falsification threshold of the toxic proteinopathy hypothesis in neurodegeneration. Handb Clin Neurol. 2023;192:143\u201354.","journal-title":"Handb Clin Neurol"},{"key":"493_CR52","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1093\/brain\/awad332","volume":"147","author":"DM Hermann","year":"2024","unstructured":"Hermann DM, Peruzzotti-Jametti L, Giebel B, Pluchino S. Extracellular vesicles set the stage for brain plasticity and recovery by multimodal signalling. Brain. 2024;147:372\u201389.","journal-title":"Brain"},{"key":"493_CR53","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1016\/j.neuron.2021.08.011","volume":"109","author":"KA Chamberlain","year":"2021","unstructured":"Chamberlain KA, Huang N, Xie Y, LiCausi F, Li S, Li Y, et al. Oligodendrocytes enhance axonal energy metabolism by deacetylation of mitochondrial proteins through transcellular delivery of SIRT2. Neuron. 2021;109:3456-3472.e8.","journal-title":"Neuron"},{"key":"493_CR54","doi-asserted-by":"publisher","first-page":"e3000621","DOI":"10.1371\/journal.pbio.3000621","volume":"18","author":"C Fr\u00fchbeis","year":"2020","unstructured":"Fr\u00fchbeis C, Kuo-Elsner WP, M\u00fcller C, Barth K, Peris L, Tenzer S, et al. Oligodendrocytes support axonal transport and maintenance via exosome secretion. PLoS Biol. 2020;18:e3000621.","journal-title":"PLoS Biol"},{"key":"493_CR55","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1038\/s41591-024-02886-y","volume":"30","author":"G Pagano","year":"2024","unstructured":"Pagano G, Taylor KI, Anzures Cabrera J, Simuni T, Marek K, Postuma RB, et al. Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson\u2019s disease. Nat Med. 2024;30:1096\u2013103.","journal-title":"Nat Med"},{"key":"493_CR56","doi-asserted-by":"publisher","first-page":"763777","DOI":"10.3389\/fnmol.2021.763777","volume":"14","author":"K Tiklov\u00e1","year":"2021","unstructured":"Tiklov\u00e1 K, Gillberg L, Volakakis N, Lund\u00e9n-Miguel H, Dahl L, Serrano GE, et al. Disease duration influences gene expression in neuromelanin-positive cells from Parkinson\u2019s disease patients. Front Mol Neurosci. 2021;14:763777.","journal-title":"Front Mol Neurosci"},{"key":"493_CR57","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s40478-023-01687-7","volume":"11","author":"T Kon","year":"2023","unstructured":"Kon T, Forrest SL, Lee S, Martinez-Valbuena I, Li J, Nassir N, et al. Neuronal SNCE transcription during Lewy body formation. Acta Neuropathol Commun. 2023;11:185.","journal-title":"Acta Neuropathol Commun"},{"key":"493_CR58","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41531-023-00604-y","volume":"9","author":"MF Altay","year":"2023","unstructured":"Altay MF, Kumar ST, Burtscher J, Jagannath S, Strand C, Miki Y, et al. Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases. NPJ Parkinsons Dis. 2023;9:161.","journal-title":"NPJ Parkinsons Dis"},{"key":"493_CR59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00401-012-0964-x","volume":"124","author":"GG Kovacs","year":"2012","unstructured":"Kovacs GG, Wagner U, Dumont B, Pikkarainen M, Osman AA, Streichenberger N, et al. An antibody with high reactivity for disease-\u03b1-synuclein reveals extensive brain pathology. Acta Neuropathol. 2012;124:37\u201350.","journal-title":"Acta Neuropathol"},{"key":"493_CR60","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-015-1485-1","volume":"131","author":"T Uchihara","year":"2016","unstructured":"Uchihara T, Giasson BI. Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol. 2016;131:49\u201373.","journal-title":"Acta Neuropathol"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-025-00493-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-025-00493-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-025-00493-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T17:02:44Z","timestamp":1750698164000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-025-00493-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["493"],"URL":"https:\/\/doi.org\/10.1186\/s40035-025-00493-6","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"8 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were performed in accordance with the guidelines for animal experimentation and approved by the Animal Research Committee of Hirosaki University (No. AE01-2024\u2013134). This study was also approved by the Institutional Ethics Committee of Hirosaki University Graduate School of Medicine (No. 2023\u2013018).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have no competing interests to report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}